Cwm LLC Has $5.26 Million Position in The Clorox Company $CLX

Key Points

• Cwm LLC increased its holdings in The Clorox Company by 21.1%, now owning 43,843 shares valued at $5.26 million.
• Several hedge funds, including Wealth Enhancement Advisory Services LLC, have also raised their positions in Clorox, reflecting growing institutional interest in the company.
• Analysts have reduced their target prices for Clorox, with the average target now at $131.64, and the company has received mostly "Hold" ratings from investment analysts.

Cwm LLC lifted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 21.1% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 43,843 shares of the company's stock after purchasing an additional 7,649 shares during the quarter. Cwm LLC's holdings in Clorox were worth $5,264,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of CLX. Wealth Enhancement Advisory Services LLC raised its position in shares of Clorox by 17.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 57,934 shares of the company's stock worth $8,531,000 after purchasing an additional 8,793 shares during the period. Exchange Traded Concepts LLC raised its position in shares of Clorox by 10.2% during the first quarter. Exchange Traded Concepts LLC now owns 3,612 shares of the company's stock worth $532,000 after purchasing an additional 333 shares during the period. Mission Wealth Management LP raised its position in Clorox by 3.6% in the 1st quarter. Mission Wealth Management LP now owns 7,653 shares of the company's stock valued at $1,127,000 after buying an additional 268 shares during the last quarter. Janney Montgomery Scott LLC raised its position in Clorox by 5.7% in the 1st quarter. Janney Montgomery Scott LLC now owns 115,552 shares of the company's stock valued at $17,015,000 after buying an additional 6,277 shares during the last quarter. Finally, QRG Capital Management Inc. raised its position in Clorox by 10.0% in the 1st quarter. QRG Capital Management Inc. now owns 2,492 shares of the company's stock valued at $367,000 after buying an additional 226 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CLX shares. Morgan Stanley dropped their target price on Clorox from $150.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, August 1st. TD Cowen dropped their target price on Clorox from $120.00 to $117.00 and set a "hold" rating on the stock in a research report on Wednesday, October 1st. The Goldman Sachs Group dropped their target price on Clorox from $115.00 to $110.00 and set a "sell" rating on the stock in a research report on Wednesday, October 1st. Jefferies Financial Group dropped their target price on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Finally, Wells Fargo & Company dropped their target price on Clorox from $130.00 to $125.00 and set an "equal weight" rating on the stock in a research report on Thursday, September 25th. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Reduce" and an average target price of $131.64.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.63% of the company's stock.

Clorox Stock Performance

Shares of NYSE CLX opened at $118.56 on Thursday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37. The stock has a 50 day moving average of $121.88 and a 200-day moving average of $128.27. The company has a market capitalization of $14.44 billion, a P/E ratio of 18.18, a P/E/G ratio of 0.99 and a beta of 0.52.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $2.87 EPS for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the previous year, the company posted $1.82 EPS. The firm's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. The ex-dividend date is Wednesday, October 22nd. Clorox's payout ratio is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.